Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) is a blank-check company that completed its initial public offering in 2021, sponsored by BVF Partners L.P., the San Francisco-based biotechnology-focused investment firm. The SPAC filed an S-1/A amendment with the SEC on May 4, 2021, under accession number 0001213900-21-024378, as part of the standard registration review process ahead of its IPO. ORIA targets acquisition opportunities in the biotechnology and life sciences sector, drawing on BVF's deep domain expertise in biopharmaceutical investing. The company was listed on the Nasdaq Capital Market. For full filing history, deal timeline, and sponsor analytics on ORIA, sign up for SpacDesk at spacdesk.com.